Intrathecal hydromorphone for cesarean delivery: In search of improved postoperative pain management: A case report

AANA Journal

Volumn 79, Issue 5, 2011, Pages 427-432

  Rauch, Erik ^a,b  

^a Bayfront Med Center St Petersburg   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cesarean delivery; Hydromorphone; Intrathecal; Pain management

Indexed keywords

CITRATE DISODIUM; DIPHENHYDRAMINE; FAMOTIDINE; HYDROMORPHONE; ONDANSETRON; OXYCODONE; OXYTOCIN; RINGER LACTATE SOLUTION;

ADULT; ANALGESIA; ANAMNESIS; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID FLOW; CESAREAN SECTION; DRUG SAFETY; FEMALE; HUMAN; INCISION; NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PREOPERATIVE CARE; PRURITUS; RECOVERY ROOM; SPINAL ANESTHESIA; UTERUS; VITAL SIGN; WOUND CLOSURE;

ANALGESIA, OBSTETRICAL; ANALGESICS, OPIOID; CESAREAN SECTION; FEMALE; HUMANS; HYDROMORPHONE; INJECTIONS, SPINAL; NURSE ANESTHETISTS; PAIN, POSTOPERATIVE; PREGNANCY; YOUNG ADULT;

EID: 82155168165     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. MacDorman MF, Menacker F, Declarcq E. Cesarean birth in the United States: epidemiology, trends, and outcomes. Clin Perinatol. 2008;35(2):293-307.
2. Coleman VH, Lawrence H, Schulkin J. Rising cesarean delivery rates: the impact of cesarean delivery on maternal request. Obstet Gynecol Surv. 2009;64(2):115-119.
3. Childbirth Connection. Rates for total cesarean section, primary cesarean section and vaginal birth after cesarean section (VBAC), United States, 1989-2006. January 2008. http://www.childbirthconnection.org/pdfs/cesarean-section-trends.pdf. Accessed May 31, 2011.
4. Rathmell JP, Lair TR, Nauman B. The role of intrathecal drugs in the treatment of acute pain. Anesth Analg. 2005;101(5 suppl):S30-S43.
5. Wagemans MF, Zuurmond WW, de Lange JJ. Long-term spinal opioid therapy in terminally ill cancer pain patients. Oncologist. 1997;2(2):70-75.
6. Hurley RW, Wu CL. Acute Postoperative Pain. In: Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Young WL, eds. Miller's Anesthesia. 7th ed. Philadelphia, PA: Churchill Livingstone; 2010:2757-2781.
7. Newsome S, Frawley BK, Argoff CE. Intrathecal analgesia for refractory cancer pain. Curr Pain Headache Rep. 2008;12(4):249-256.
8. Sloan PA. Neuraxial pain relief for intractable cancer pain. Curr Pain Headache Rep. 2007;11(4):283-289.
9. Bennett G, Burchiel K, Buschser E, et al. Clinical guidelines for intraspinal infusion: report of an expert panel: PolyAnalgesic Consensus Conference. J Pain Symptom Manage. 2000;20(2):S37-S43.
10. Flaherty SA. A Comparison of Analgesic Efficacy, Patient Satisfaction, and Cost of Three Spinal-Epidural Analgesic Regimens in the Laboring Parturient [doctoral dissertation]. Chicago, Ill: Rush University College of Nursing; 1996. CINAHL Database Accession No. 1999070460.
11. The Unnecesarean. Re: C-section rate rises: 2007 U.S. cesarean rate hit 31.8 percent. 2009. http://www.theunnecesarean.com/blog/2009/3/18/c-section-rate-rises-2007-us-cesarean-rate-hit-318-percent.html. Accessed February 8, 2010.
12. Ruan X. Drug-related side effects of long-term intrathecal morphine therapy. Pain Physician. 2007;10(2):357-366.
13. Anderson VC, Cooke B, Burchiel KJ. Intrathecal hydromorphone for chronic nonmalignant pain: a retrospective study. Pain Med. 2001;2(4):287-297.
14. Ackerman LL, Follett KA, Rosenquist RW. Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/ opioid combinations. J Pain Symptom Manage. 2003;26(1):668-677.
15. Reich A, Szepietowski JC. Opioid-induced pruritus: an update. Clin Exp Dermatol. 2009;35(1):2-6.
16. Ganesh A, Maxwell LG. Pathophysiology and management of opioidinduced pruritus. Drugs. 2007;67(16):2323-2333.
17. Du Pen S, Du Pen A, Hillyer J. Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study. Pain Med. 2006;7(1): 10-15.